110 related articles for article (PubMed ID: 17201121)
21. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation.
Hsue SS; Chen YK; Lin LM
Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609
[TBL] [Abstract][Full Text] [Related]
22. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
Fuessel S; Herrmann J; Ning S; Kotzsch M; Kraemer K; Schmidt U; Hakenberg OW; Wirth MP; Meye A
Cancer Lett; 2006 Feb; 232(2):243-54. PubMed ID: 16458121
[TBL] [Abstract][Full Text] [Related]
23. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
Yoo J; Lee YJ
Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
[TBL] [Abstract][Full Text] [Related]
24. Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells: Direct suppression of survivin and enhancement of transfection efficiency by topotecan.
Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
Int J Oncol; 2008 Jan; 32(1):171-6. PubMed ID: 18097556
[TBL] [Abstract][Full Text] [Related]
25. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy response in oral squamous carcinoma cell lines: evaluation of apoptotic proteins as prognostic factors.
Roberg K; Jonsson AC; Grénman R; Norberg-Spaak L
Head Neck; 2007 Apr; 29(4):325-34. PubMed ID: 17163470
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
Kim KS; Yoon JH; Kim JK; Baek SJ; Eling TE; Lee WJ; Ryu JH; Lee JG; Lee JH; Yoo JB
Biochem Biophys Res Commun; 2004 Dec; 325(4):1298-303. PubMed ID: 15555568
[TBL] [Abstract][Full Text] [Related]
28. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
Yuan-Jing F; Nan-Shan H; Lian X
Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
[TBL] [Abstract][Full Text] [Related]
29. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship?
Lo Muzio L; Campisi G; Giovannelli L; Ammatuna P; Greco I; Staibano S; Pannone G; De Rosa G; Di Liberto C; D'Angelo M
Oral Oncol; 2004 Aug; 40(7):736-41. PubMed ID: 15172644
[TBL] [Abstract][Full Text] [Related]
30. KO-202125, a sauristolactam derivate, induces apoptosis to prevent KB human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression.
Leem DH; Choi KH; Han HS; Kim JH; Shin JA; Choi ES; Shim JH; Kong G; Min YK; Nam JS; Oh SH; Kim KA; Kwon KH; Cho NP; Cho SD
Eur J Cancer Prev; 2010 Jan; 19(1):23-30. PubMed ID: 19910795
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
[TBL] [Abstract][Full Text] [Related]
32. Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells.
Xu J; Huang H; Pan C; Zhang B; Liu X; Zhang L
Int J Oral Maxillofac Surg; 2007 Aug; 36(8):739-44. PubMed ID: 17611077
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells.
Hideshima T; Catley L; Raje N; Chauhan D; Podar K; Mitsiades C; Tai YT; Vallet S; Kiziltepe T; Ocio E; Ikeda H; Okawa Y; Hideshima H; Munshi NC; Yasui H; Richardson PG; Anderson KC
Br J Haematol; 2007 Sep; 138(6):783-91. PubMed ID: 17760810
[TBL] [Abstract][Full Text] [Related]
34. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
35. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
Kardosh A; Soriano N; Pyrko P; Liu YT; Jabbour M; Hofman FM; Schönthal AH
J Biomed Sci; 2007 Sep; 14(5):647-62. PubMed ID: 17440835
[TBL] [Abstract][Full Text] [Related]
36. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions.
Campisi G; Di Fede O; Giovannelli L; Capra G; Greco I; Calvino F; Maria Florena A; Lo Muzio L
Oral Oncol; 2005 Nov; 41(10):994-1004. PubMed ID: 16129653
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
[TBL] [Abstract][Full Text] [Related]
38. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
39. Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells.
Seo SK; Jin HO; Lee HC; Woo SH; Kim ES; Yoo DH; Lee SJ; An S; Rhee CH; Hong SI; Choe TB; Park IC
Mol Pharmacol; 2008 Mar; 73(3):1005-12. PubMed ID: 18156316
[TBL] [Abstract][Full Text] [Related]
40. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
